Clinical Trials News
Pharmaceutical Giants Race to Develop Next-Gen Hepatitis Cure
In the hunt for a more efficient hepatitis cure, Bristol-Myers Squibb Co plans to test its own experimental antiviral drug combination with Gilead Sciences Inc’s groundbreaking Solvaldi. Their goal is to cut …
Are New HCV Drugs Like Solvaldi Too Expensive?
Over two decades of intensive work and research have helped to produce drugs that are now capable of curing people who’ve contracted hepatitis C. This is an all too important topic in the …
Free Screenings for Baby Boomers this Hepatitis Awareness Month
Did you know that the month of May is actually Hepatitis Awareness Month? Now, we understand that this might not be the sort of thing people want to think about just as we …
Our Guideline for Preventing the Transmission of Hepatitis C
For anyone who has been diagnosed with hepatitis C, they may be worried about transmitting this infectious disease to any of their friends or family. This can become a difficult issue for …
A New Hope to Cure Chronic Hepatitis C
A new drug combination has cured 70 percent of the patients it is administered to in early stage hepatitis C clinical trials. With the latest recommendations from the Centers for Disease Control …
Could Better Syringe Programs Reduce the Rate of Hepatitis C?
In Australia, there has been a sizeable reduction in the number of new hepatitis C cases amongst users of injectable narcotics. This new trend was reported in the American Journal of Public …
The Global Effect of Hepatitis C and Liver Cancer
For anyone who has contracted the hepatitis C virus (HCV), this infection can cause irreparable damage to their liver which results in lifelong illness. HCV is transmitted when a person comes into …
As Number of Hep C Cases Increase, Treatment Options Expand
Health care officials estimate that hepatitis C affects an estimated 4 million people in the United States alone, and to make matters worse, most people don’t even realize it. Hepatitis C is …
Abbott’s New Hep C Drugs Produce High Cure Rates in Trials
Abbott Laboratories has been seeing some significant success with their new trio of oral drugs developed to treat hepatitis C. In fact, the latest results from one of their clinical trials for …
A New Hep C Vaccine on the Horizon
Recently, medical researchers completed a phase 1 clinical trial which tested the safety and efficacy of a new vaccine for hepatitis C. Early reports state that the results have so far been …